Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab.

@article{Lora2013AutoantibodyIA,
  title={Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab.},
  author={Viviana Lora and Chiara Bonaguri and Paolo Gisondi and Franca Sandei and Luisita Battistelli and Annalisa Russo and Alessandra Melegari and Tommaso Trenti and Giuseppe Lippi and Giampiero Girolomoni},
  journal={Immunologic research},
  year={2013},
  volume={56 2-3},
  pages={382-9}
}
This study was aimed to analyse the prevalence of antinuclear antibodies in patients with psoriasis after treatment with infliximab and correlates the development of antibodies with both response to treatment and adipokines levels. Serum levels of ANA, anti-dsDNA, anti-histone, anti-nucleosome and anti-ENA antibodies at baseline after 2 and 12 months of treatment with infliximab were measured in 27 patients with psoriasis, as well as in 27 matched controls. Serum C-reactive protein (CRP… CONTINUE READING